Literature DB >> 8980901

Site-directed mutagenesis of recombinant equine chorionic gonadotropin/luteinizing hormone: differential role of oligosaccharides in luteinizing hormone- and follicle-stimulating hormone-like activities.

K S Min1, N Hattori, J Aikawa, K Shiota, T Ogawa.   

Abstract

Equine chorionic gonadotropin (eCG) consists of highly glycosylated alpha- and beta-subunits and belongs to the glycoprotein hormone family that includes LH and FSH. eCG is a unique member of the gonadotropin family because it elicits response characteristics of both FSH and LH in other species than the horse. To determine the biological role of the N-linked oligosaccharide at Asn 56 of the alpha-subunit and O-linked oligosaccharides at the carboxyl-terminal peptide (CTP) of the beta-subunit, two mutant eCGs, in which Asn 56 of the alpha-subunit was replaced with Gln (eCG alpha 56/beta) or CTP was deleted (eCG alpha/ beta-CTP), were produced by site-directed mutagenesis and transfecting chinese hamster ovary (CHO-K1) cells. LH- and FSH-like activities were assayed in terms of testosterone production and aromatase activity in primary cultured rat Leydig cells and granulosa cells, respectively. The wild type eCG showed similar LH- and FSH-like activities to native eCG in the in vitro bioassays. The LH-like activity of eCG alpha 56/beta was greatly reduced, whereas that of eCG alpha/beta-CTP was unaffected, demonstrating that the oligosaccharide at Asn 56 of the alpha-subunit of eCG plays an indispensable role in LH-like activity. Interestingly, the FSH-like activity of eCG alpha 56/beta was increased markedly in comparison with the wild type, and that of eCG alpha/beta-CTP was also considerably increased. These data indicate that the dual activities of eCG, LH- and FSH-like activities, could be separated by removal of the N-linked oligosaccharide on the alpha-subunit Asn 56 or CTP-associated O-linked oligosaccharides.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980901     DOI: 10.1507/endocrj.43.585

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  6 in total

1.  Internalization of Rat FSH and LH/CG Receptors by rec-eCG in CHO-K1 Cells.

Authors:  Jong-Ju Park; Hun-Ki Seong; Jeong-Soo Kim; Byambaragchaa Munkhzaya; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2017-06-30

2.  Signal Transduction of Eel Luteinizing Hormone Receptor (eelLHR) and Follicle Stimulating Hormone Receptor (eelFSHR) by Recombinant Equine Chorionic Gonadotropin (rec-eCG) and Native eCG.

Authors:  Munkhzaya Byambaragchaa; So-Yun Lee; Dae-Jung Kim; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2018-03-31

3.  Characterization of tethered equine chorionic gonadotropin and its deglycosylated mutants by ovulation stimulation in mice.

Authors:  Kwan-Sik Min; Jong-Ju Park; Munkhzaya Byambaragchaa; Myung-Hwa Kang
Journal:  BMC Biotechnol       Date:  2019-08-13       Impact factor: 2.563

4.  Comparative gene expression profiling of mouse ovaries upon stimulation with natural equine chorionic gonadotropin (N-eCG) and tethered recombinant-eCG (R-eCG).

Authors:  Kwan-Sik Min; Jong-Ju Park; So-Yun Lee; Munkhzaya Byambaragchaa; Myung-Hwa Kang
Journal:  BMC Biotechnol       Date:  2020-11-11       Impact factor: 2.563

5.  Roles of N-linked and O-linked glycosylation sites in the activity of equine chorionic gonadotropin in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor.

Authors:  So-Yun Lee; Munkhzaya Byambaragchaa; Seung-Hee Choi; Han-Ju Kang; Myung-Hwa Kang; Kwan-Sik Min
Journal:  BMC Biotechnol       Date:  2021-09-05       Impact factor: 2.563

6.  Specific Biological Activity of Equine Chorionic Gonadotropin (eCG) Glycosylation Sites in Cells Expressing Equine Luteinizing Hormone/CG (eLH/CG) Receptor.

Authors:  Munkhzaya Byambaragchaa; Seung-Hee Choi; Hyo-Eun Joo; Sang-Gwon Kim; Yean-Ji Kim; Gyeong-Eun Park; Myung-Hwa Kang; Kwan-Sik Min
Journal:  Dev Reprod       Date:  2021-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.